Cirius
Investment
area
Novo Ventures
Novo Ventures
Region
Eastern USA
Eastern USA
Date of
investment
March 2017
March 2017
Website
https://ciriustx.com/
https://ciriustx.com/
Cirius is a clinical stage biotechnology company developing MSDC-0602, a PPAR sparing thiazolidinedione (TZD) for non-alcoholic hepatosteatosis (NASH).
Cirius
Investment
area
Novo Ventures
Novo Ventures
Region
Eastern USA
Eastern USA
Date of
investment
March 2017
March 2017
Website
https://ciriustx.com/
https://ciriustx.com/
Cirius is a clinical stage biotechnology company developing MSDC-0602, a PPAR sparing thiazolidinedione (TZD) for non-alcoholic hepatosteatosis (NASH).
Cirius
Investment
area
Novo Ventures
Novo Ventures
Region
Eastern USA
Eastern USA
Date of
investment
March 2017
March 2017
Website
Visit their website
Visit their website
Cirius is a clinical stage biotechnology company developing MSDC-0602, a PPAR sparing thiazolidinedione (TZD) for non-alcoholic hepatosteatosis (NASH).